글로벌 수의학 항균제 감수성 테스트 시장 규모, 점유율 및 추세 분석 보고서 – 산업 개요 및 2031년까지의 예측

수의학 항균제 감수성 테스트 시장 분석

수의학적 항균제 감수성 검사 시장은 식품 생산 동물과 반려동물 모두에서 감염성 질환의 유병률이 증가하고 항생제 내성에 대한 인식이 높아짐에 따라 상당한 성장을 목격하고 있습니다. 수의사와 애완동물 주인이 효과적이고 책임감 있는 항생제 사용의 필요성을 더욱 의식하게 되면서 치료 결정을 안내할 수 있는 정확한 검사 방법에 대한 수요가 증가하고 있습니다. 자동화된 검사 장비와 신속한 검사 솔루션의 개발과 같은 기술적 발전은 항균제 감수성 검사의 효율성과 정확성을 향상시키고 있습니다. 또한 수의학에서 책임감 있는 항생제 사용을 촉진하기 위한 규제 지원과 이니셔티브가 시장 성장을 뒷받침하고 있습니다. 수의학 참고 연구실, 연구소, 병원을 포함한 다양한 최종 사용자가 있기 때문에 동물의 감염성 질환을 효과적으로 관리해야 하는 중요한 필요성을 해결하는 보다 혁신적인 검사 솔루션이 도입됨에 따라 시장이 확대될 것으로 예상됩니다.

수의학 항균제 감수성 테스트 시장 규모

글로벌 수의학 항균제 감수성 검사 시장 규모는 2023년에 396억 1천만 달러로 평가되었으며, 2031년까지 596억 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 CAGR은 5.24%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

수의학 항균제 감수성 테스트 시장 동향

“ 항생제 관리 에 대한 강조 증가 ”

수의학적 항균제 감수성 검사 시장은 항생제 내성에 대한 우려가 커지고 반려동물과 식품 생산 동물 모두에서 감염성 질환이 증가함에 따라 상당한 성장을 경험하고 있습니다. 시장에서 중요한 추세 중 하나는 수의학적 관행에서 책임감 있는 항생제 사용을 장려하는 항생제 관리에 대한 강조가 커지고 있다는 것입니다. 수의사가 내성 위험을 최소화하면서 치료 결과를 최적화하기 위해 노력함에 따라 정확한 항균제 감수성 검사에 대한 수요가 증가하고 있습니다. 또한 신속한 검사 기술과 분자 진단의 발전으로 이러한 검사의 속도와 정확도가 향상되어 시장 성장이 더욱 촉진되고 있습니다. 전반적으로 수의학적 항균제 감수성 검사 시장은 검사 방법의 혁신과 관리에 대한 집중으로 수의학적 치료의 풍경이 재편됨에 따라 지속적인 확장이 예상됩니다.

보고 범위 및 수의학 항균제 감수성 테스트 시장 세분화

Veterinary Antimicrobial Susceptibility Testing Market Definition

Veterinary Antimicrobial Susceptibility Testing (VAST) refers to a laboratory procedure used to determine the effectiveness of antimicrobial agents against specific bacteria or pathogens isolated from animals. This testing helps veterinarians identify which antibiotics or antimicrobial drugs are most effective in treating infections in animals, ensuring appropriate treatment choices that can improve animal health and reduce the risk of antibiotic resistance. VAST plays a critical role in veterinary medicine, particularly in managing infectious diseases, guiding treatment protocols, and promoting responsible use of antimicrobials in animal husbandry.

Veterinary Antimicrobial Susceptibility Testing Market Dynamics

Drivers

• Rising Prevalence of Antimicrobial Resistance

The rising prevalence of antimicrobial resistance (AMR) in animals is a critical market driver for the veterinary antimicrobial susceptibility testing (AST) sector. AMR poses a serious threat to animal health and welfare and undermines the effectiveness of antimicrobial treatments, leading to prolonged illness and increased mortality rates among livestock and pets. Veterinary antimicrobial susceptibility testing plays a vital role in this context by identifying the most effective antimicrobial agents for treating infections, thus helping to combat the challenge of AMR. By using AST, veterinarians can tailor treatment plans to ensure the selection of appropriate antimicrobials, improving treatment outcomes and minimizing the risk of resistance development. Such growing recognition of the importance of AST in managing AMR is driving demand in the veterinary sector, thereby significantly contributing to the expansion of the veterinary antimicrobial susceptibility testing market.

• Increasing Incidence of Infectious Diseases

The increasing incidence of infectious diseases among both companion and food-producing animals is a major driver of the veterinary antimicrobial susceptibility testing market. As outbreaks of infections such as canine parvovirus and feline leukemia become more common, veterinarians are faced with the challenge of effectively diagnosing and treating these diseases. For instance, a report from the American Veterinary Medical Association indicated that there has been a noticeable rise in antibiotic-resistant bacterial infections in livestock, necessitating the use of precise antimicrobial susceptibility testing to identify effective treatment options. This growing prevalence of infectious diseases heightens the demand for accurate testing and underscores the importance of tailored therapeutic approaches in veterinary medicine. As a result, the urgency to manage these infectious diseases effectively is propelling the market for antimicrobial susceptibility testing solutions, reinforcing the need for advanced diagnostic tools in veterinary practices.

Opportunities

• Increasing Adoption of Point-of-Care Testing

Point-of-care testing (POCT) involves performing diagnostic tests and obtaining results in real-time at the site of patient care. The adoption of POCT in veterinary medicine is on the rise, presenting a significant opportunity for the development of portable and user-friendly antimicrobial susceptibility testing devices that can be utilized directly in veterinary clinics or in the field. These rapid testing solutions offer immediate results, enabling veterinarians to make prompt treatment decisions based on the specific antimicrobial resistance patterns of the pathogens involved. This capability enhances the quality of care provided to animals and contributes to more effective disease management and better patient outcomes. By facilitating timely interventions, POCT can play a crucial role in improving overall animal health and welfare.

• Expansion of Veterinary Reference Laboratories

Veterinary reference laboratories are essential in delivering specialized diagnostic services, particularly antimicrobial susceptibility testing, to veterinary clinics and hospitals. As the demand for precise and comprehensive diagnostic testing rises, these laboratories have a significant opportunity for expansion. By investing in advanced testing technologies, such as automated systems and molecular diagnostics, veterinary reference labs can enhance their efficiency and accuracy in diagnosing infections. In addition, expanding their testing capacities enables them to accommodate a larger volume of samples and offer a broader array of antimicrobial susceptibility testing services. Such strategic growth helps meet the increasing market demand and supports veterinarians in making informed treatment decisions, ultimately improving animal health outcomes and promoting responsible antibiotic use in veterinary medicine.

Restraints/Challenges

• High Costs of Antimicrobial Susceptibility Testing

The high costs associated with antimicrobial susceptibility testing represent a significant barrier for veterinary clinics, particularly in developing regions where budget constraints restrict access to advanced diagnostics. Many veterinary practices, especially smaller clinics, may find it challenging to invest in the necessary testing equipment and reagents, which can be prohibitively expensive. This financial hurdle can lead to a reliance on traditional treatment methods without the benefit of tailored antimicrobial therapy, potentially resulting in ineffective treatment outcomes and contributing to the rise of antimicrobial resistance. As a consequence, the lack of affordable testing options limits the overall adoption of antimicrobial susceptibility testing in veterinary medicine. This challenge hampers market growth, as the inability to conduct effective testing may undermine efforts to improve animal health and welfare.

• Stringent Regulatory Standards

The veterinary antimicrobial susceptibility testing market encounters significant regulatory hurdles that can impede the approval and commercialization of new diagnostic products. Stringent regulatory requirements often necessitate extensive clinical trials and comprehensive documentation to demonstrate the safety and efficacy of testing devices and procedures. These lengthy processes can delay the introduction of innovative solutions into the market, which is critical for addressing emerging challenges related to antimicrobial resistance in veterinary medicine. Furthermore, navigating the complex landscape of regulations across different countries can be daunting for companies, especially smaller firms lacking the resources to manage compliance effectively. As a result, these regulatory challenges can hinder the timely availability of advanced diagnostic tools, limiting the market's growth and reducing veterinarians' ability to implement effective antimicrobial stewardship practices.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Veterinary Antimicrobial Susceptibility Testing Market Scope

The market is segmented on the basis of product type, animal type, and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Disks and Plates
• Culture Media
• Accessories and Consumables
• Automated Antimicrobial Susceptibility Testing Instruments

Animal Type

• Food-producing Animals
  • Cattle
  • Poultry
  • Pigs
  • Others (Sheep, Goats, Veal)
• Companion Animals
  • Dogs
  • Cats
  • Horses
  • Others (Birds, Fish, Turtles)

End User

• Veterinary Reference Laboratory
• Veterinary Research Institutes and Universities
• Others

Veterinary Antimicrobial Susceptibility Testing Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, product type, animal type, and end-user as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America leads the global veterinary antimicrobial susceptibility testing market due to its robust and advanced healthcare infrastructure, particularly in veterinary care. The region is equipped with an extensive network of veterinary clinics, diagnostic laboratories, and research institutions, all of which possess the resources and expertise required to conduct antimicrobial susceptibility testing effectively.

Asia-Pacific region is anticipated to experience significant growth from 2024 to 2031, driven by its large and expanding population that is increasingly demanding animal protein, such as meat, milk, and eggs. The intensification of animal production systems and the higher density of livestock can lead to the spread of infectious diseases and antimicrobial resistance. Consequently, there is an escalating need for effective diagnostics, including antimicrobial susceptibility testing, to safeguard the health and productivity of livestock and aquaculture.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Veterinary Antimicrobial Susceptibility Testing Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Veterinary Antimicrobial Susceptibility Testing Market Leaders Operating in the Market Are:

• BD (U.S.)
• Synbiosis (U.S.)
• Zhuhai DL Biotech Co., Ltd. (China)
• Mast Group Ltd. (U.K.)
• HiMedia Laboratories (India)
• Thermo Fisher Scientific Inc. (U.S.)
• Bio-Rad Laboratories, Inc. (U.S.)
• Creative Diagnostics (U.S.)
• Genefluidics, Inc. (U.S.)
• ROSCO DIOGNISTICA (Germany)
• Erba Mannheim (U.S.)
• Liofilchem S.r.l. (Italy)
• Alifax S.r.l. (Italy)
• MERLIN Gesellschaft für mikrobiologische Diagnostika mbH (Germany)
• BIOMÉRIEUX (France)
• Merck KGaA (U.S.)
• Danaher (U.S.)
• Accelerate Diagnostics, Inc. (U.S.)
• NuMedii, Inc. (U.S.)

Latest Developments in Veterinary Antimicrobial Susceptibility Testing Market

• In June 2023, bioMérieux achieved a remarkable milestone by receiving nine IMV ServiceTrak clinical laboratory awards. These awards recognized the company’s excellence across several key segments, including Immunoassay, ID/AST, and Blood Culture, highlighting its commitment to delivering high-quality diagnostic solutions and reinforcing its leadership position in the clinical laboratory market
• In April 2023, Bio-Rad Laboratories, Inc. introduced the ID-Check Speciation Solution, a cutting-edge tool designed to determine the animal species origin of meat samples. This innovative solution is invaluable for food, feed, and environmental testing, ensuring accurate identification and enhancing food safety and traceability in the supply chain
• 2022년 10월, Bioguard Corporation은 동물 건강 진단 센터에 대한 ISO 17025 인증을 받음으로써 중요한 이정표를 달성했습니다. 이 인증은 실험실 관행에서 높은 표준을 유지하고 진단 서비스가 국제적 품질 요구 사항을 충족하며 수의학 전문가가 신뢰할 수 있도록 보장하려는 조직의 노력을 강조합니다.
• 2022년 8월, Becton, Dickinson and Company는 Accelerate Diagnostics, Inc.와 상업적 협력 계약을 체결했습니다. 이 전략적 파트너십은 Accelerate의 포괄적인 항생제 내성 및 감수성 제품 포트폴리오의 유통을 강화하여 효과적인 감염 관리에 필수적인 고급 진단 도구에 대한 접근성을 개선하는 것을 목표로 합니다.
• 2021년 6월, bioMérieux는 Specific Diagnostics와 유통 계약을 체결하여 유럽 전역에 REVEAL Rapid AST 시스템을 유통했습니다. 이 파트너십을 통해 bioMérieux는 항균제 감수성 검사 솔루션 포트폴리오를 확장하여 해당 지역의 의료 서비스 제공자에게 신속하고 정확한 진단을 제공하는 역량을 강화할 수 있습니다.

SKU-66356